Q3 is in the books and according to Crosscadia venture capital invested in the Pacific Northwest region was up $600 million from the previous quarter.

Notable contributions from Vancouver helped boost the region’s numbers, while the Seattle-area remained the most active market.

There were 29 venture capital financing deals in B.C. in Q3 with a median average of US $5.4 million.

This impressive average was skewed by Clio’s massive US $250 million round with secondary support from Chinook Therapeutics’ US $65 million Series A, Trulioo’s US $53 million Series C, and Terramera’s $45 million round.

Check out Crosscadia’s complete Q3 Review below.